EPCAM and ameloblastic carcinoma: Finding this unexpected result, we decided to include in the study also the malignant counterpart of AM; ameloblastic carcinoma, finding strong positivity in the only two cases included, this over-regulation of Ep-CAM seems to coincide with what happens in most of the epithelial malignant neoplasms.